US Broker Ratings

BioMarin Pharmaceutical Inc. (BMRN): Investor Outlook with a 48.89% Potential Upside

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) stands out in the biotechnology sector with a focus on developing therapies for rare and life-threatening diseases. With a current market capitalization of $11.4 billion,..

BrightSpring Health Services, I (BTSG): Strong Buy Ratings Signal Investor Confidence Despite Valuation Challenges

BrightSpring Health Services, Inc. (BTSG) is making waves in the healthcare sector with its robust platform offering home and community-based healthcare services. Operating primarily in the United States, BrightSpring provides..

Tenet Healthcare Corporation (THC) Stock Analysis: Unlocking a 28.67% Potential Upside in the Healthcare Sector

For investors seeking opportunities in the healthcare sector, Tenet Healthcare Corporation (NYSE: THC) presents a compelling case. With a potential upside of 28.67% based on current analyst ratings, Tenet Healthcare..

Sanofi (SNY) Stock Analysis: A Compelling 30% Upside Potential Amidst Strong Dividend Yield

Sanofi (NASDAQ: SNY), a stalwart in the global healthcare sector, continues to capture investor attention with its robust dividend yield and promising growth potential. With a market capitalization of $102.81..

iRhythm Holdings, Inc. (IRTC) Stock Analysis: Unveiling a Promising 50% Upside Potential

iRhythm Holdings, Inc. (NASDAQ: IRTC) has been making waves in the healthcare sector, particularly within the medical devices industry, with its innovative cardiac monitoring solutions. As a digital healthcare company..

Rhythm Pharmaceuticals, Inc. (RYTM) Stock Analysis: A Biotech with Promising Upside and Strong Buy Ratings

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) is making waves in the biotechnology sector, capturing investor attention with its promising pipeline focused on rare neuroendocrine diseases. With a current market capitalization of..

Madrigal Pharmaceuticals, Inc. (MDGL) Stock Analysis: A 32% Upside Opportunity in the Biotech Sector

Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a dynamic player in the biotechnology sector, offers investors a compelling opportunity with a potential upside of 32.39%. Specializing in novel therapeutics for metabolic dysfunction-associated..

Neurocrine Biosciences, Inc. (NBIX) Stock Analysis: Navigating a 15.35% Upside Potential in the Healthcare Sector

Neurocrine Biosciences, Inc. (NBIX) is capturing investor attention with a compelling upside potential of 15.35%, positioning itself as a promising player in the healthcare sector, specifically within the specialty and..

Humana Inc. (HUM) Stock Analysis: Evaluating Growth Amidst a Stretched Valuation

Humana Inc. (NYSE: HUM), a stalwart in the healthcare plans industry, boasts a market capitalization of $46.08 billion, marking its prominence within the United States’ healthcare sector. Despite its impressive..

Integer Holdings Corporation (ITGR) Stock Analysis: Navigating the Healthcare Device Sector with Strategic Growth

Integer Holdings Corporation (NYSE: ITGR) stands as a formidable entity in the healthcare sector, specifically within the medical devices industry. With a market capitalization of $3.19 billion, this Texas-based company..

Alnylam Pharmaceuticals, Inc. (ALNY) Stock Analysis: A Biotech Powerhouse with a Potential 49.75% Upside

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY), a trailblazer in the biotechnology sector, is making waves with its innovative RNA interference therapeutics. With a market capitalization of $38.9 billion, the company is..

Qiagen N.V. (QGEN) Stock Analysis: Exploring an 11.55% Potential Upside in the Healthcare Sector

As a key player in the healthcare sector, Qiagen N.V. (NYSE: QGEN) stands out with its robust offerings in the diagnostics and research industry. With a market capitalization of $8.13..

Revvity, Inc. (RVTY) Stock Analysis: Navigating the Diagnostics & Research Sector with a $12.61 Billion Market Cap

Revvity, Inc. (NYSE: RVTY), a prominent player in the healthcare sector, offers a compelling investment narrative within the diagnostics and research industry. Renowned for its cutting-edge health sciences solutions, Revvity..

Ionis Pharmaceuticals, Inc. (IONS) Investor Outlook: Strong Buy Ratings and 30% Upside Potential

Ionis Pharmaceuticals, Inc. (IONS), a leading player in the biotechnology sector, is offering investors a compelling opportunity with its innovative RNA-targeted medicines. With a market capitalization of $13.42 billion, Ionis..

Roivant Sciences Ltd. (ROIV) Stock Analysis: A Biotech Powerhouse with 14.59% Potential Upside

Roivant Sciences Ltd. (NASDAQ: ROIV) stands as a formidable player in the biotechnology sector, headquartered in London, United Kingdom. With a market capitalization of $24.51 billion, the company has captured..

AptarGroup, Inc. (ATR) Investor Outlook: Exploring a 27% Potential Upside in the Healthcare Sector

AptarGroup, Inc. (NYSE: ATR), a prominent player in the healthcare sector, has garnered attention from investors seeking stable growth and a promising upside. With a market capitalization of $8.04 billion,..

Globus Medical, Inc. (GMED) Stock Analysis: Uncovering a 25.96% Upside Potential for Investors

Globus Medical, Inc. (NYSE: GMED) stands out in the healthcare sector as a formidable player in the medical devices industry, focusing on innovative solutions for musculoskeletal disorders. With a market..

Teleflex Incorporated (TFX) Stock Analysis: A Closer Look at Its 12.34% Potential Upside

Teleflex Incorporated (NYSE: TFX) is a prominent player in the healthcare sector, specializing in the medical instruments and supplies industry. With a market capitalization of $5.75 billion, this U.S.-based company..

Universal Health Services, Inc. (UHS) Stock Analysis: A 46.77% Upside Potential Beckons Investors

Universal Health Services, Inc. (NYSE: UHS), a stalwart in the healthcare sector, stands at a pivotal intersection for investors seeking opportunities in medical care facilities. With a market capitalization of..

Chemed Corp (CHE) Stock Analysis: Navigating Growth in Healthcare with a Strong ROE of 25.6%

Chemed Corp (NYSE: CHE) stands as a formidable player in the healthcare sector, specifically in the medical care facilities industry. With a market capitalization of $6.15 billion, this Cincinnati-based company..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds